>sp|Q9QSQ7.1|ENV_HV1VI RecName: Full=Envelope HIV-1 group m gen env
HACVPTDPNPQEVFLKNVTENFDMWKNNMVEQMHTDIISLWDQSLKPCVKLTPLCVTLNCTNATNNSQEK
PGAMQNCSFNMTTEVRDKKLKLSALFYRLDIVPIGNNNSSEYRLINCNTSTITQACPKVSWDPIPIHYCA
PAGYAILKCNDKRFNGTGPCKNVSTVQCTHGIKPVVSTQLLLNGSLAEEGIVIRSQNISNNAKTIIVHLN
ESVQINCTRPNNNTRKGIHLGPGQTFYATGAIIGDIRKAHCNISGTQWNNTLEYVKAELKSHFPNNTAIK
FNQSSGGDLEITMHSFNCRGEFFYCDTSGLFNDTGSNNGTITLPCRIKQIVNMWQGVGRAMYTSPIAGNI
TCNSNITGLLLTRDGGNESNIETFRPEGGNMKDNWRSELYKYKVVEIEPLGVAPTKAKRQVVQREKRAAG
LGALFLGFLGDSREHMGAASITLTVQARQLLSGIVQQQNNLLRAIEAQQHLLQLTVWGIKQLQARVLAVE
RYLKDQQLLGIWGCSGKLICTTNVPWNSSWSNKSQEEIWNNMTWMEWEKEISNYSNIIYKLIEESQNQQE
KNEQELLALDKWASLWNWFDISNWLWYIKIFIMIVGGLIGLRIVFAVLSIVNRVRKGYSPLSLQTLIPSP
RGPDRPEGIEEGGGEQGKDRSVRLVTGFLALAWDDLRNLCLFSYRHLRDFILIAARIVDRGLRRGWEALK
YLGNLTRYWSQELKNSAISLFNTTAIVVAEGTDRIIEVLQRAGRAVLNIPRRIRQGAERALL

>sp|Q9IDV2.1|ENV_HV1YB HIV-1 group N gen env
QEVLLTNVTEYFNMWENKMAEQMQEDIISLWEQSLKPCVKLTPLCVTMLCNNSNGNSAGNSTTNRTEDLE
DRQMKNCSFNITTEIRDRKKQVYSLFYVEDVVPIKDGTDNNTYRLINCNTTAVTQACPKTTFEPIPIHYC
APPGFAIMKCNEGNFSGNGSCTNVSTVQCTHGIKPVISTQLILNGSLDTDDIVIRHHGGNLLVQWNETVS
INCTRPGNNTGGQVQIGPAMTFYNIEKIVGDVRQAYCNVSEEWGSMWNKTKKKIKRLLGNNTTFKAQDKN
GGDLEVTHLMFNCXGEFFYCNTSRLFNESENKTNKTIILPCRIKQIVBLWTRVXKGIYAPPIRGNLSCXS
SITGLILEHSGENGNKTVYPSGGNMVNLWRQELYKYKVVSIEPIGVAPGKAKRRTVSREKRAAFGLGALF
LGFLGAAGSTMGAASITLTVQARTLLSGIVQQQNNLLRAIEAQQHLLQLSIWGIKQLRAKVLAIERYLRD
QQILSLWGCSGKTICYTTVPWNDTWSSNTSYDTIWXNLTWQQWDRKVRNYSGVIFDLIEQAQEQQNTNEK
ALLELDQWASLWNWFDITKWLWYIKIAIMVVAGIIGIRIISAIITIIARVRQGYSPLSLQTLIPTAARGP
DRPEETEEGVGGQDRGRSVRLVSGFLALIWEDLRNLLIFLYHRLADSLLIIRRTLEILGQSLSRGLQLLN
ELRIRLWGIIAYWGKELKDSAISLLNTTAIVVAEGTDRFIELAQRIGRGILHIPRRIRQGLERALL

>sp|Q79670.1|ENV_HV1MV HIV-1 group O gen env
MTVTMKVMKKNNRKSWSLYIAMALLIPCLSYSKQLYATVYSGVPVWEEAAPVLFCASDANLTSTEQHNIW
ASQACVPTDPNPHEFPLGNVTDNFDIWKNYMVDQMHEDIISLWEQSLKPCEKMTFLCVQMNCVDLQTNKT
GLLNETINEMRNCSFNVTTVLTDKKEQKQALFYVSDLSKVNDSNAVNGTTYMLTNCNSTIIKQACPKVSF
EPIPIHYCAPTGYAIFKCNDTDFNGTGLCHNISVVTCTHGIKPTVSTQLILNGTLSREKIRIMGKNITES
AKNIIVTLNTPINMTCIREGIAEVQDIYTGPMRWRSMTLKRSNNTSPRSRVAYCTYNKTVWENALQQTAI
RYLNLVNQTENVTIIFSRTSGGDAEVSHLHFNCHGEFFYCNTSGMFNYTFINCTKSGCQEIKGSNETNKN
GTIPCKLRQLVRSWMKGESRIYAPPIPGNLTCHSNITGMILQLDQPWNSTGENTLRPVGGDMKDIWRTKL
YNYKVVQIKPFSVAPTKMSRPIINIHTPHREKRAVGLGMLFLGVLSAAGSTMGAAATALTVRTHSVLKGI
VQQQDNLLRAIQAQQHLLRLSVWGIRQLRARLQALETLIQNQQRLNLWGCKGKLICYTSVKWNTSWSGRY
NDDSIWDNLTWQQWDQHINNVSSIIYDEIQAAQDQQEKNVKALLELDEWASLWNWFDITKWLWYIKIAII
IVGALIGIRVIMIILNLVKNIRQGYQPLSLQIPVPHRQEAETPGRTGEEGGEGDRPKWTALPPGFLQQLY
TDLRTIILWTYHLLSNLISGIRRLIDYLGLGLWILGQKTIEACRLCGAVMQYWLQELKNSATNLLDTIAV
SVANWTDGIILGLQRIGQGFLHIPRRIRQGAERILV

>sp|P04580.1|ENV_HV1Z6 HIV-1 group unknown env
MRAREIERNCPNLWKWGIMLLGILMICSAADNLWVTVYYGVPVWKEATTTLFCASDAKSYKTEAHNIWAT
HACVPTDPNPQEIELENVTENFNMWRNNMVEQIHEDIISLWDQSLKPCVKLTPLCVTLNCTDESDEWMGN
VTGKNVTEDIRMKNCSFNITTVVRDKTKQVHALFYRLDIVPIDNDNSTNSTNYRLINCNTSAITQACPKV
SFEPIPIHYCAPAGFAILKCRDKRFNGTGPCTNVSTVQCTHGIRPVVSTQLLLNGSLAEEEIIIRSENLT
NNAKIIIVQLNESVAINCTRPYKNTRQSTPIGLGQALYTTRGRTKIIGQAHCNISKEDWNKTLQRVAIKL
GNLLNKTTIIFKPSSGGDAEITTHSFNCGGEFFYCNTSGLFNSTWNINNSEGANSTESDNKLITLQCRIK
QIINMWQGVGKAMYAPPIEGQINCSSNITGLLLTRDGGTNNSSNETFRPGGGDMRDNWRSELYKYKVVKI
EPLGVAPTKAKRRVVEREKRAIGLGAMFLGFLGAAGSTMGAASVTLTVQARQLMSGIVQQQNNLLRAIEA
QQHLLQLTVWGIKQLQARILAVERYLKDQQLLGIWGCSGKLICTTTVPWNSSWSNRSLNDIWQNMTWMEW
EREIDNYTGLIYRLIEESQTQQEKNEQELLELDKWASLWNWFNITQWLWYIKIFIMIVGGLIGLRIVFAV
LSLVNRVRQGYSPLSFQTLLPAPREPDRPEGIEEEGGERGRDRSIRLVNGFSALIWDDLRNLCLFSYHRL
RDLILIAARIVELLGRRGWEALKYLWNLLQYWSRELRNSASSLLDTIAIAVAEGTDRVIEIVRRTYRAVL
NVPTRIRQGLERLLL

>sp|P20872.2|ENV_HV2ST HIV-2 subtype A env
MCGRNQLFVASLLASACLIYCVQYVTVFYGVPVWRNASIPLFCATKNRDTWGTIQCLPDNDDYQEIALNV
TEAFDAWNNTVTEQAVEDVWSLFETSIKPCVKLTPLCVAMRCNSTTAKNTTSTPTTTTTANTTIGENSSC
IRTDNCTGLGEEEMVDCQFNMTGLERDKKKLYNETWYSKDVVCESNDTKKEKTCYMNHCNTSVITESCDK
HYWDTMRFRYCAPPGFALLRCNDTNYSGFEPNCSKVVAATCTRMMETQTSTWFGFNGTRAENRTYIYWHG
RDNRTIISLNKFYNLTVHCKRPGNKTVVPITLMSGLVFHSQPINRRPRQAWCWFKGEWKEAMKEVKLTLA
KHPRYKGTNDTEKIRFIAPGERSDPEVAYMWTNCRGEFLYCNMTWFLNWVENRTNQTQHNYVPCHIKQII
NTWHKVGKNVYLPPREGQLTCNSTVTSIIANIDGGENQTNITFSAEVAELYRLELGDYKLIEVTPIGFAP
TPVKRYSSAPVRNKRGVFVLGFLGFLTTAGAAMGAASLTLSAQSRTLLAGIVQQQQQLLDVVKRQQEMLR
LTVWGTKNLQARVTAIEKYLKDQAQLNSWGCAFRQVCHTTVPWVNDTLTPDWNNMTWQEWEQRIRNLEAN
ISESLEQAQIQQEKNMYELQKLNSWDVFGNWFDLTSWIKYIQYGVYIVVGIIVLRIVIYVVQMLSRLRKG
YRPVFSSPPAYFQQIHIHKDREQPAREETEEDVGNSVGDNWWPWPIRYIHFLIRQLIRLLNRLYNICRDL
LSRSFQTLQLISQSLRRALTAVRDWLRFNTAYLQYGGEWIQEAFRAFARATGETLTNAWRGFWGTLGQIG
RGILAVPRRIRQGAEIALL

>sp|Q89607.1|ENV_HV2EH HIV-2 subtype B env
MAHVNNYLLVTLLLISIYGYMGKNFVTVFYGIPAWKNASIPLFCATRNRDTWGTVQCLPDNDDYTEIQLN
ITEAFDAWDNTVTDQATKDVWSLFETSIKPCVKLTPLCVTMKCNKTWSSASKETTTSSASLRSSTQTLLN
EDSKCIQNDSCAGIGLEEMIDCQFKMTGLKRDESKQYKDTWYKQDLVCEKGTRSNESKCYIKTCNTSIIQ
ESCDKHYWDSLRFRYCAPPGFALLRCNDTKYSGFMPNCSKVVVSLYRMMETQTSTWFGFNGTRAENRTYI
YWHGKDNRTIISLNSYYNLTMHCKRPGNKMVVPIRTVSGILFHSQPINKRPKQAWCWFKGNWTEAIQEVK
ETIKNHPRYSGTTNISQIRLAEHARSSDPEVRYMWTNCRGEFLYCNMTFFLNWVENRTGLKRNYASCHIR
QIVNTWHKIGRNVYLPPREGELSCNSTVTSLIANIDWIDKNLTNITVSAEVSELYKLELGDYKLVEITPI
GFAPTSIKRYSSVTPRNKRGVLVLGFLGFLATAGSAMGAASLTLSAQSRTLLAGIVQQQQQLVDVVKRQQ
ELLRLTVWGTKNLQARVTAIEKYLKDQAQLNSWGCAFRQVCHTTVPWVNESLKPDWNNMTWQQWERQVRF
LDANITKLLEEAQIQQEKNMYELQKLNQWDIFSNWFDFTSWMAYIRLGLYIVIGIVVLRIAIYIIQMLAR
LRKGYRPVFSSPPSYTQQIPIRKDRGQPANEETEEGGGNNEGYRSWPWQIEYIHFPIRQLRDLLIWLYSG
CRTLLSKTFQTLQPVLQPLRLPPAYLRYGISWFQEAIQAAARAAGETLASAARTSWGVLRRAAGEIIAIP
RRIRQGAELALL


>sp|P24105.1|ENV_HV2CA RecName: HIV-2 isolate cam2
MERGRNQLLIAILLASACLIYCRQQYVTVFYGVPAWKNASIPLFCATKNRDTWGTIQCLPDNDDYQEIPL
NVTEAFDAWDNTITEQAIEDVWNLFETSIKPCVKLTPLCVAMKCNISTSDTTMIRTTTPSTAKEAPISDN
SPCIRTNNCSGLEEEKIVKCHFNMTGLERDKKKQYNETWYSSDVVCDNSTDQTTNETTCYMNHCNTSVIT
ESCDKHYWDAMRFRYCAPPGFAILRCNDTKYSGFAPNCSKVVASTCTRMMETQTSTWFGFNGTRAENRTY
IYWHGKDNRTIISLNKHYNLSMYCRRPGNKTVVPITLMSGQRFHSRPIINKRPRQAWCWFKGNWTEAMQE
VKQTLAEHPRYKGTKNITDITFKAPERGSDPEVTYMWSNCRGEFFYCNMTWFLNWVENKPNTTKRNYAPC
HIRQIINTWHKVGKNVYLPPREGELTCNSTVTSIIANIDERDNQTTNITFSADVAELYRLELGDYKLVEI
TPIGFAPTSQKRYSPAHGRPKRGAFVLGFLGFLTTAGVAMGTASLTLSAQSRTLLAGIVQQQQQLLDVVK
RQQELLRLTVWGTKILQARVTAIEKYLKDQAQLNSWGCAFRQVCHTTVPWANESLTPDWNNMTWQEWEQK
VRYLEANISQSLEEAQLQQEKNMYELQKLNNWDVFTNWFDLTSWISYIQYGVYIVVGIIVLRIVIYVVQM
LSRLRKGYRPVFSSSPGYIQQIHIHKDPEQPASEETEEDVGGNGGDRSWPWQIEYIHFLIRQLIRLLTGL
YNICRNLLSRIFQTLQPILQNLRDWLRPKVAFLQYGCEWIQEAFQAAARAARETLAGACRDVWGMLQRIG
RGILAVPRRIRQGAELALL

>sp|P17755.2|ENV_HV2D1 HIV-2 isolate D194
MEPGRNQLLVAILLTSACLIYCKQYVTVFYGIPAWRNASIPLFCATKNRDTWGTIQCLPDNDDYQEITLN
VTEAFDAWDNTVTEQAIEDVWRLFETSIKPCVKLTPLCVAMNCNITSGTTATPSPPNITIIDENSTCIGD
NNCTGLGKEEVVECEFNMTGLEQDKKRKYNDAWYSRDVVCDKTNGTGTCYMRHCNTSVIKESCDKHYWDA
MKFRYCAPPGFALLRCNDTNYSGFEPKCSKVVAASCTRMMETQTSTWFGFNGTRAENRTYIYWHGKDNRT
IISLNKYYNLTMHCKRPGNKTVVPITLMSGRRFHSRPVYNKKPGQAWCWFQGNWIEAMREVKQTLAKHPR
YGGTNDTGKINFTKPGIGSDPEVTYMWTNCRGEFLYCNMTWFLNWVENKTNQTHGNYAPCHIRQIINTWH
KVGTNVYLPPREGELTCNSTVTSIIANIDSDGNQTNITFSAEVAELYRLELGDYKLIEVTPIPFAPTKEK
RYSSAPVRNKRGVFVLGFLGFLATAGSAMGGASLTLSAQSRTLLAGIVQQQQQLLDVVKRQQEMLRLTVW
GTKNLQARVTAIEKYLKDQAQLNSWGCAFRQVCHTTVPWVNDSLTPDWNNMTWQEWEKRVHYLEANISQS
LEQAQIQQEKNMYELQKLNSWDVFGNWFDLTSWIKYIQYGVYIVVGIIGLRIAIYIVQLLSRLRKGYRPV
FSSPPGYLQQIHIHTDRGQPANEETEEDAGDDSGFGLWPWPLNYIQFLIHLLTRLLTGLYNSCRGLLSKN
SPTRRLISQSLTAIRDWLRLKAAYLQYGCEWIQEAFRAFARTARETIAGAWRGLCEAAQRIGRGILAVPR
RIRQGAEIALL

>sp|P18040.1|ENV_HV2G1 HIV-2 isolate Ghana1
MCGKSLLCVASLLASAYLVYCTQYVTVFYGVPVWRNASIPLFCATKNRDTWGTIQCKPDNDDYQEITLNV
TEAFDAWDNTVTEQAVEDVWSLFETSIKPCVKLTPLCVAMSCNSTTNNTTTTGSTTGMSEINETSPSYSD
NCTGLGKEEIVNCQFYMTGLERDKKKQYNETWYSKDVVCESNNTKDGKNRCYMNHCNTSVITESCDKHYW
DAIKFRYCAPPGYALLRCNDTNYSGFEPKCSKVVASTCTRMMETQTSTWFGFNGTRAENRTYIYWHGRDN
RTIISLNKYYNLSIHCKRPGNKTVVPITLMSGLVFHSQPINTRPRQAWCWFKGKWREAMQEVKQTLIKHP
RYKGTNDTKNINFTKPGRGSDPEVAYMWTNCRGEFLYCNMTWFLNWVENRPNQTQHNYAPCHIRQIINTW
HKVGKNVYLPPREGQLTCNSTVTSIIANIDVNSNQTNITFSAEVAELYRLELGDYKLIEVTPIGFAPTRE
KRYSSAPVRNKRGVFVLGFLGFLATAGSAMGAASLTLSAQSRTLLAGIVQQQQQLLDVVKRQQEMLRLTV
WGTKNLQARVTAIEKYLKDQAQLNSWGCAFRQVCHTTVPWVNDSLSPDWNNMTWQEWEKQVRYLEANISQ
SLEQAQIQQEKNMYELQKLNSWDVFGNWFDLTSWIKYIQYGVYIVVGVIVLRIAIYIVQLLSRLRKGYRP
VFSSPPGYLQQIHIHTDRGQPANEGTEEDDRDDDGYDLPWPINYIHFLIHLLTRLLTGLYKICRDLLSTN
SPTHRLISQNLTAIRDWLRLKAAYLQYGGEWIQEAFQAFAKTTRETLASAWGGLCAAVQRVGRGILAVPR
RIRQGAEIALL

>sp|Q74126.1|ENV_HV2KR HIV-2 isolate KR
MDSRNQLIVAILLTSACLIYCAQYVTVFYGIPAWKNASIPLFCATRNRDTWGTIQCLPDNDDYQEIPLNV
TEAFDAWNNTVTEQAVEDVWNLFETSVKPCVKLTPLCVQMECNSTSTESSNSTSEGSTVPEILNETTSCI
TNNSCSDLGSEEVVDCRFNMTGLQLDKPQQYSETWYSKDVVCDTTNGTSRKCYMNHCNTSVITESCDKHY
WDAMRFRYCAPPGLCLLRCNDTNYSGFEPKCPKVVAATCTRMMETQTSTWFGFNGTRAENRTYIYWHGRD
NRTIISLNTHYNLTMHCKRPGNKSVLPITLRSGRVFHSRPIINERPKQAWCWFGGDWKKAMQEVKQTLVK
HPRYRGTNDTQKINFTQPGKGSDAEVVYMWTNCRGEFLYCNMTRFLNWIENRAHPQRNYAPCHIRQIINT
WHRVGQNIYLPPREGELVCNSTVTSIIANIDMFDNQTSITFSAEVAELYRLELGDYKLVEITPIGFAPTS
EKRYSSAPQRNKRGVFVLGVLGFLATAGSAMGAASLTLSAHPGLYWAGIVQQQQQLLDVVKRQQEMLRLT
VWGTKNLQTRVTAIEKYLRDQARLNSWGCAFRQVCYTTVLWENNSIVPDWNNMTWQEWEQQTRDLEANIS
RSLEQAQIQQEKNMYELQKLNSWDVFGNWFDLTSWIKYIQYGVYVIIGIIALRIVIYVVQLLSRLRKGYR
PVFSSPPGYIQQIHIHKDWEQPDREETDEDAGNSIGDSSWPWPIAYIHFLIRQLIRLLTGLYSVCKDLLS
RSFPTLQLIFQSLQRALTTIRDWLRLTIAYLQYGCEWIQEVLQVLARTTRETLASAWRDLWGAMGRIGRG
ILAVPRRIRQGAELALL

>tr|A0A0E3T4M8|A0A0E3T4M8_SIV Envelope glycoprotein gp160 OS=Simian immunodeficiency virus OX=11723 GN=env PE=3 SV=1
MRVMGTKKSCVLYYCLVILSLFSLTIDSKEELWVTVYYGVPVWRDAETTLFCASDAKAQE
TEAHNIWASQACVPTDPNPEEIHLPNVTEYFDMWKNNMVEQMQEDIISLWDQSLKPCVKL
TPLCVTLNCTNCIWGNGTFREWNDTREDLRNCSFNAGDIRDKKKRVHSLFYAEDIILIDR
TRTTKQGNSTQAPATTPIASTKVPDSNDTCSPNNTLEYRLISCNTSVITQACPKTSFEPI
PIHYCAPAGFALLKCNDTNFSGQGICRNVSTVHCTHGIRPVVSTHLLLNGSLAKGDIMIR
VKNKNQSTDTIIVQLNKSINITCIRPGNNTIKGIPIGPGQHFYGTETVVGDTRKAYCKIN
GTQWFDTLKRVAWELKETFNLTRVTFDQASPGDPEIQKHYFNCGGEFFYCETSSLFNATI
DITPNTTLNETTWDYPAENNINQEMIIHCRIKQIVSMWQRVGKGIFSPPIRGTIQCNSTI
TGLLLTRDGNNKADSENKTRIETGQNKAEEINRTDIFRPAGGEMRDNWRSELYRYKVVKI
EPLGLAPTKAKRRTVNREKRAPGLGLMFLGFLGAAGSTMGAASLTLTVQARQLLTGIVQQ
QSNLLRAIEAQQHLLQLSVWGIKQLQARVLAIERYLKDQQLLGIWGCSGKLICTTDVKWN
ETWSNKSYNEIWDNMTWMQWDKEVRNYTETIYDLIEQAQNQQEYNEKSLLELNQWASLWN
WFDISNWLWYIKIFIMIVGGLIGCRIVFALLSIVNRVRQGYSPLSFQTLFPIPRGPEQPG
ETGEEGGEQDNVRSIRLLNGFLPLVWNDLRDLCRFLYHRLRDFLLIARRTLELVGQHLLK
GLRLVWETLLYLKGVLQYWGRELKVSAISLLDTTAIAVAEGTDRIIEVAQRFGRGILNIP
TRIRQGLERALL

>tr|Q5W9H3|Q5W9H3_SIV Envelope glycoprotein gp160 OS=Simian immunodeficiency virus OX=11723 GN=env PE=3 SV=1
MRVKEKYQHLWRWGWKWGTMLLGILMICSATEKLWVTVYYGVPVWKEATTTLFCASDAKA
YDTEVHNVWATHACVPTDPNPQEVVLVNVTENFNMWKNDMVEQMHEDIISLWDQSLKPCV
KLTPLCVSLKCTDLKNDTNTNSSSGRMIMEKGEIKNCSFNISTSIRDKVQKEYAFFYKLD
IVPIDNTSYRLISCNTSVITQACPKVSFEPIPIHYCAPAGFAILKCNNKTFNGTGPCTNV
STVQCTHGIRPVVSTQLLLNGSLAEEDVVIRSANFTDNAKTIIVQLNTSVEINCTRPNNN
TRKSIRIQRGPGRAFVTIGKIGNMRQAHCNISRAKWNATLKQIASKLREQFGNNKTIIFK
QSSGGDPEIVTHSFNCGGEFFYCNSTQLFNSTWFNSTWSTEGSNNTEGSDTITLPCRIKQ
FINMWQEVGKAMYAPPISGQIRCSSNITGLLLTRDGGNNNNGSEIFRPGGGDMRDNWRSE
LYKYKVVKIEPLGVAPTKAKRRVVQREKRAVGIGALFLGFLGAAGSTMGAASMTLTVQAR
QLLSDIVQQQNNLLRAIEAQQHLLQLTVWGIKQLQARILAVERYLKDQQLLGIWGCSGKL
ICTTAVPWNASWSNKSLEQIWNNMTWMEWDREINNYTSLIHSLIEESQNQQEKNEQELLE
LDKWASLWNWFNITNWLWYIKLFIMIVGGLVGLRIVFAVLSIVNRVRQGYSPLSFQTHLP
IPRGPDRPEGIEEEGGERDRDRSIRLVNGSLALIWDDLRSLCLFSYHRLRDLLLIVTRIV
ELLGRRGWEALKYWWNLLQYWSQELKNSAVNLLNATAIAVAEGTDRVIEVLQAAYRAIRH
IPRRIRQGLERILL

>tr|Q1A252|Q1A252_SIV Envelope glycoprotein gp160 OS=Simian immunodeficiency virus OX=11723 GN=env PE=3 SV=1
MRVKGTWTSCMPYYVVGILSLCSLIISSTKNENLWVTVYYGVPVWKEAEATLFCASDAKA
QKAEAHNIWASQACVPTDPDPKAIELSNVTENFNMWTNAMVNQMQQDVISLWDQSLKPCI
KLTPLCVTLHCSIPKFDNSSINSSNETMKNCSFNTTTELRDKKKQTYSLFYVDDLTQINK
TTESYKLINCNTTAITQACPKISFEPIPIHYCAPAGFALLRCNNKTYNGSGPCNNVSTVH
CTHGIKPVISTQLILNGSLAEEKIMIRYKADKVLVQLNTSIHINCTRVGNKTIKGIPLGP
GQLFYGTETVVGDTREAHCEINQTHWYKILNQVKRELTTVFNESNKTVHFANSSGGDPEV
ANLHFNCGGEFFYCNTSALFNDTLLRNKTLLNETLHNNLTLPCRIRQIVNLWLRVGKGIF
APPIRGNIRCNSTITGLILEKHTNTDNITFRPIGGDMTDIWRSELYNYKIVKIEPLGVAP
TRARRRTVDREKRAAGLGVFFLGFLGAAGSTMGAASLTLTVQARQLLTGIVQQQSNLLRA
IEAQQHLLQLSVWGIKQLQARVLAIERYLKDQQLLGIWGCSGKLICTTSVPWNRTWSNKT
YNEIWDNMTWMEWDREVRNYTEIIYGLIEQAQDQQENNEKKLLELDHWTSLWNWFDISHW
LWYIKIFIMIIGGLIVCRIIFAVLAIVNRVRQGYSPLSFQTLSPIPRGLAQPGGTEEEGG
EQGTDRSVRLLDGFLALAWNDLRDLCLFLYHRLTDLVLIARRTLEIVGQYTLKGLRLVWE
ALLYLQGILQYWGKELKTSATSLLDTTAIAVAEGTDRIIEIVQRIGRGILHIPRRIRQGF
ERALL

>tr|S4ST55|S4ST55_SIV Envelope glycoprotein gp160 OS=Simian immunodeficiency virus OX=11723 GN=env PE=3 SV=1
MRVMGTKKSCVLYYCLVILSLFSLTIDSKEELWVTVYYGVPVWRDAETTLFCASDAKAQE
XEAHNIWASQACVPTDPNPEEIHLPNVTEYFDMWKNNMVEQMQEDIISLWDQSLKPCVKL
TPLCVTLNCTNCIWGNGTFREWNDTREDLRNCSFNAGDIRDKKKRVHSLFYAEDIILIDR
TRTTKQGNSTQAPATTPIASTXVPDSNDTCSPNNTLEYRLISCNTSVITQACPKTSFEPI
PIHYCAPAGFALLKCNDTNFSGQGICXNVSTVHCTHGIRPVVSTHLLLNGSLAKGDIMIR
VKDXXQXTDXIIVQLNXSINITCIRPGNNTIKGIPIGPGQHFYGTETVVGDTRKAYCKIN
GTQWFDTLKRVAWELKETFNLTRVTFDQASPGDPEIQKHYFNCGGEFFYCETSSLFNATI
DITPNTTLNETTWDYPAENNINQEMIIHCRIKQIVSMWQRVGKGIFSPPIRGTIQCNSTI
TGLLLTRDGNNKADSENKTRIETGQNKAEEINRTDIFRPAGGEMRDNWRSELYRYKVVKI
EPLGLAPTKAKRRTVNREKRAPGLGLMFLGFLGAAGSTMGAASLTLTVQARQLLTGIVQQ
QSNLLRAIEAQQHLLQLSVWGIKQLQARVLAIERYLKDQQLLGIWGCSGKLICTTDVKWN
ETWSNKSYNEIWDNMTWMQWDKEVRNYTETIYDLIEQAQNQQEYNEKSLLELNQWASLWN
WFDISNWLWYIKIFIMIVGGLIGCRIVFALLSIVNRVRQGYSPLSFQTLFPIPRGPEQPG
ETGEEGGEQDNVRSIRLLNGFLPLVWNDLRDLCRFLYHRLRDFLLIARRTLELVGQHLLK
GLRLVWETLLYLKGVLQYWGRELKVSAISLLDTTAIAVAEGTDRIIEVAQRFGRGILNIP
TRIRQGLERALL

>tr|B0LBA0|B0LBA0_SIV Envelope glycoprotein gp160 OS=Simian immunodeficiency virus OX=11723 GN=env PE=3 SV=1
MKVMGTQRSWKQFLSLRIVMCLWLLGVIRSENNLWVTVYYGVPVWKEAKTTLFCASDAKA
QIAEAHNIWASQACVPTDPNPEEITLENVTEEFDAWNNNMVDQMQEDLISLWDQSLKPCV
KLTPLCVTLNCSTNTTTEASQVQYNCSFNVTTELRDKKKQVYSLFYREDITSLDSNKTVK
NGTYRLINCNTTAITQACPKTSFEPIPIYYCAPAGFALLKCNDQNFKGKGTCRNVSTVHC
THGIKPVVSTQFLLNGSLAEGNKTVVRVRSKSNTETIIVQLATAIYINCTRLGNKTIEGI
PIGPGQIFYRTKTVVGDTRGAECRINGTAWNETLRQVKEALNNTYRNLNLSLTEINFEGA
SGGDLEVTTHYFNCGGEFFYCNTSNLFNQSTINNITHIPCRIRQIVNQWQGVGKGIFAPP
IRGTIQCNSTITGLLLTRDGKNETETFRPTGGDMRNNWRSELYKYKVVKIEPLGLAPTKA
KRRTVQREKRAVGLGVMFLGFMGAAGSTMGAAALTLTVQARNLLSGIVQQQSNLLKAIEA
QQHLLQLSVWGIKQLQARVLAVERYLKDQQLLGLWGCSGKLICTTNVPWNNTWSKKLGTN
LSFWDNMTWMQWEKEIDNYTETIYELLTRSQNQQEVNEQELLALDKWSSLWNWFDITQWL
WYIKLFVMIVGGLIGIRIVFAMLSIVNRVRQGYSPLSFQTPFPVRRDPDRPEGIEEGGGE
NDNVRSVRLVSGFLALAWDDLRNLCLFSYHRLRDLLWIVRRTLEIVGQKFLAGLRLVWET
LTYLKSILQYWGQELKTSAISLLDATAIAVAEGTDRIIEIAQRVGRGILHIPRRIRQGLE
RALL

>tr|Q9Q072|Q9Q072_SIV Envelope glycoprotein gp160 OS=Simian immunodeficiency virus OX=11723 GN=env PE=3 SV=1
MKVMEKIKGSLIEKYMFMGLIIPCLTGSDQLWATVYYGVPVWKEADTTLFCASEASALNK
EAHNIWASQACVPTDPNPQEVQIPNVTENFNMWNNTMAEQMNTDIISLWDQSLKPCVKLT
PICVTMECRKVTFNSTSNRNKTSTMTTNSPNEKXDSTVKNCTFNMTTEVRDKEKKVYSLF
YVDDLVLIDNDTDTYRLINCNTTAITQACPKTSFEPIPIHYCATPGYAIMKCNMPNFNGT
GTGRCNNISTVQCTHGIRPVVTTQLILNGSVAENKTIARRNGYXFLXQFQXXVSINCTRP
GNXSRGQIQIGPGMTFYNIENIVGDTRRAYCQINRTVWDERLNETGQALRELFTNLTQVN
FTVSPGGDPEVTNMMFNCGGEFFYCNTTTLFNYTWKNNNITKGDNTTFFPCRIRQIVNSW
MRVGKGIYAPPIRGVISCTSNVTGIILETGHGINNSITNITLYPTGGNMVDLWRLELHKY
KVVSIEPIGVAPSKAKRHTVSREKRAAFGLGALFLGFLGAAGSTMGAASVVLTVQARQLL
SGIVQQQNNLLRAIEAQQHLLQLSVWGIKQLQARVLAVERYLRDQQILGLWGCSGKAICY
TTVPWNNTWSANTSFDEIWNNLTWQDWDKRVKNYSGVIFSLIEQAQEQQNTNEKSLLELD
QWSSLWNWFDITRWLWYIKLFIMIVAGLVGIRIVGAIISFVAKVRQGYSPLSLQTLIPTT
REPDRPGGTEEDVGEPGKGRSIRLVSGFLALIWEDLRNLLLFCYHRLRDLLLILGRTLEN
LGQSLNKGLQQLRNFSRYLWGVITYWGRELQTSAISLLDATAIAVAEGTDRILEVAQIIG
RGILHIPRRIRQGLERSLL

>tr|I2BF65|I2BF65_SIV Envelope glycoprotein gp160 OS=Simian immunodeficiency virus OX=11723 GN=env PE=3 SV=1
MKVTEMQKNWLICCLLIGLIKIIGSELWVTVYYGVPVWRDAETVLFCASDAKAHSTEAHN
IWATQACVPTDPNPQEVLIPNVTERFDMWKNNMVDQMQEDIISLWEQSLKPCVKLTPLCV
TLSCSSWRSVNNSVNQTNHVQMQNCSFNVTTELRDKKKQVYSLFYMGDIIPLDTNNSSGN
NSQYRLINCNTTAVTQACPKISFEPIPIYYCAPPGFAIIKCNDQDFNGTGECNNVSTVQC
THGIKPVISTQLILNGSLATSNIVIRNNSKDTLLVQLNESIPINCTRPGNKTRGQVQIGP
GMTFYNIENIIGDTRQAYCEVNRTWEQIWNTTKQIIINNRKNITFIPNPGGDLEVTNLMI
NCGGEFFYCNTSQLFTNQNGNTTGNITLQCRIRQIVNLWTRVGKGIYAPPIKGPINCLSN
ITGIILDYTKSGTEKYTIYPTGGDMTNLWRQELYKYKVVSIEPIGVAPGKAKRHTVTRQK
RAAFGLGALFLGFLGAAGSTMGAASITLTVQARKLLSGIVQQQNNLLRAIEAQQHLLQLS
VWGIKQLQARVLAIERYLRDQQILGLWGCSGKSVCYTNVPWNTTWSNNNSYDTIWGNMTW
QNWDEQVRNYSGVIFGLLEQAQEQQSINEKSLLELDQWSSLWNWFDITKWLWYIKIFIMV
VAGIVGIRIISIIMSMVARVRQGYSPLSLQTLIPTTRGPDRPERTEEDAGELDNGRSVRL
VSGFLALAWEDFRNLLLFLYHRLTDCLSILRRTLELLRQNIHKGLQLLNELRIYLWGIIA
YWGRELKISAINLLDTTAVAVAEGTDRIIELVQRIGRGILHIPRRIRQGLERALL

>tr|Q9ICT2|Q9ICT2_SIV Envelope glycoprotein gp160 OS=Simian immunodeficiency virus OX=11723 GN=env PE=3 SV=1
MKAMERKKLNWIICYMLMGLITPCLTGHEWWATVYYGVPVWKEAETTLFCASEASALNKE
AHNIWASQACVPVDPNPQEVYMPNVSESFNMWKNNMAEQMQEDISSLWDQSLKPCVKLTP
ICVTMQCTTLKNISTTNTNSTELKNIKEIMKNCTFNMTTEVRDKKKEVYSLFYVDDIVPI
GGNKSNDTYRLINCNTTTVTQACPKTSFEPIPIHYCAPPGFAIMKCNDQKFNGTGPCTNI
STVQCTHGIRPVVTTQVILNGSLAEEGPAVARSEDLRHKIIIIQFKEGINIICMRPGNNS
RGQLQIGPGVSFYNIENIVGDPRQAHCNVSKAQWMKKLNETALAIAKYDKSIAKVTFTPN
PGGDPEITNMMFNCGGEFFYCNTTPLFNKFNYTCDNQNNCTRNNTNDTNSDNSTLTISCR
IRQIVNSWMRVGKGIYAPPIRGNITCISNITGLLLEAGGKWENNTITVYPSGGEMRDLWR
LELNRYKVVSIEPIGVAPTKAKRHTVAREKRAAFGLGALFLGFLGAAGSTMGAASVVLTV
QARHLLSGIVQQQNNLLRAIEAQQHLLQLSVWGIKQLQARVLAVERYLKDQQILSLWGCS
GKAICYTTVPWNATWSANTSYDEIWNNLTWQDWDKKVKNYSGVIFSLIEQAQEQQNTNEK
DLLELDQWSSLWSWFNITQWLWYIKIFLIVVAGLIGFRLIGIVMSVIAKVRQGYSPLSLQ
TLIPTTREPDRRGGTEEDGGEPGRGRSTRLVSGFLALVWEDLRNLLIFFYHRLIDLLSIL
WRTVQILGQSINKGLQQLKDFSTYLKGVLTYWGREIQISATSLLDTTAIAVANGTDRIIE
FVQIVGRGILHIPRRIRQGLERSLL

>tr|Q5MYY2|Q5MYY2_SIV Envelope glycoprotein gp160 OS=Simian immunodeficiency virus OX=11723 GN=env PE=3 SV=1
MKVMEERKRSFNGFYMTMTICMALLIPCLTSDEWVTVYYGVPVWREVNTVLFCASDAKAH
STEAHNIWATHACVPTDPNPQEVVLHNVTEDFNMWNNQMVEQMQEDISSLWDQSLKPCVK
LTPLCVTMKCSNVTRQNSTSNSNNNPTLKNNTSGKNETGVLQMKNCTFNTTTELRDKKKQ
VYSLFYVDDLQSLGSGTGDTYTMINCNTTAITQACPKVSFEPIPIHYCAPAGFAILKCND
VNFSGKGKCRNVSTVHCTHGIKPVVTTQLIINGSLATENITVRVNNASKNTHDWIVQLST
AVNLTCKRVGNNTRGKVQIGPGMTFYNMDHIFGDTRKAFCELNGTTWNETLQKVRESLIK
EIKANANGTYNITFEPSSGGDPEIANHMFNCGGEFFYCDTRKMFNESEPFHENMTIPCRI
RQIVNSWMRVGRGIYAPPIPGHITCNSLITGLILTRDHVNNTNNTFRPIGGDMKNIWRSE
LYKYKVVRIEPLSVAPTKAKRHTVGERRQKRAAFGLGALFLGFLGAAGSTMGAAAVTLTV
QARQLLSGIVQQQNNLLRAIEAQQHLLQLTVWGVKQLQARLLAVERYLQDQQILGLWGCS
GKSICYTTVPWNKTWSGKSMSDIWNNLTWQQWDKLITNYTGTIFGLLEEAQSQQEKNEKD
LLELDQWASLWNWFDITNWLWYIKIFLMAVGGIIGLRIIMSVVSVIRRVRQGYSPLSLQT
LIPAQREPGTLGETGGEGGEPGSGRSVRLVTGCWPLIWDDLRNLVIWSYRSLTSLACIVW
RQLEKLGQLLINILRLIQEKLTLLRGIIQYWGRELRTSATSLLDATAIAVGEGTDRIIRA
VQIVFRIIGNIPRRIRQGLERTLL

>tr|Q9YL63|Q9YL63_SIV Envelope glycoprotein gp160 OS=Simian immunodeficiency virus OX=11723 GN=env PE=3 SV=1
MKVMEKKKRLWLSYCLLSSLIIPGLSSLWATVYYGVPVWRDVETTLFCASDAKAYKQEAH
NIWATQACVPTDPNPQEVHLPNVTEKFDMWENNMAEQMQEDIISLWDQSLKPCIKLTPLC
VTMTCLNPDSNSSAVNTTDIMRNCSFNITTELRDKKKQVYSLFYVDDLAHINNNTYRLIN
CNTTAITQACPKTSFEPIPIHYCAPPGFAILKCNEKDFKGKGECKNVSTVQCTHGIKPVV
TTQLIINGSLATKNVTVRSKNFADIILVQFSEGVNMTCIRPGNNTVGNVQLGPGMTFYNI
PKIVGDVREAHCNISKLTWEKQRKYTLEIIKKEANLTKVELIPNAGGDPEVVNMMLNCGG
EFFYCNTIPLFNMTYNNTDNTTITLKCRIRQIVNQWMRVGKGIFAPPIKGVLSCNSNITG
MILDISISAVNNDSRNITVMPTGGDMTALWKNELHKYKVVSIEPIGVAPGKAKRHTVKRE
KRAAFGLGALFLGFLGAAGSTMGAASVVLTVQARQLLSGIVQQQNNLLRAIEAQQHLLQL
SVWGIKQLQARVLAVERYLKDQQILGLWGCSGKTICYTTVPWNDTWSNNLSYDAIWGNLT
WQEWDRKVRNYSGTIFSLIEQAQEQQNTNEKSLLELDQWSSLWNWFDITNWLWYIKIFLI
VVASLVGIRIVGVIFSLVAKVRQGYSPLSLQTLFPTTREPDRPEGTEEGAGKTDNVRSTR
LVSGFLALVWEDLRNLLIFLYHRLEDLLLILRRTVQILGQNINKGLQLLNELRARCWGVI
AYWARELKVSATSLLDTTAIAVAEGTDRIIELTRRLFLGIIHIPRRIRQGLERSLL

>tr|P89688|P89688_9RETR Env polyprotein OS=Feline immunodeficiency virus OX=11673 GN=env PE=4 SV=1 gp150
MAEGGRVDVVERADEELGRQGVEGHEYAFGMNPDWIGPYEGEMLLDFDILQYVTEEGPFR
PGHNPFRAPGITEQERQELCVMLQDKLKEIKGTITEGPHKIPPGKYRRLRYLQYSDMQVT
QSLALLVFDISHYLRNKLGKEVYDIEGDRQAEYKFEKRVKGRTYNNCRCRLLLIGAGFFY
TCLIIGLGCLIRETSGVILALDPPWVIPVTKMDEINFQCHGNYEECPVLESVATWKTDFQ
WNYSRPFNETIGLEQYVDQIQAKALQDLLGSCQKLSKNKLGVLQWRCFYDRGMKQLLGLQ
KIRICPIGGYMLVRKIDENNYTLSMCTEEIDIKILNMTLSQEKYEHYPFNDIVWMGNRYF
NMTTANITQQQVNISIKCDIIVPTVVKVKKEFAGYNNDFLGPWGGLKYRSILIRYKDWAN
VTDPPLDLNCTGLPGIALNGTEANYTCAQNATITYGDICTQPELYVPCYSPNYSMPVMVQ
CKLHQEYHPNDTYRNSSNDMQVMRCRIMKEVELRFGDEFISLNFTLLRDPFLAHLRGAIN
FTCNLTGQFWAYKFNNATWGYEGNGSAWNESLNWLVPYRNYTKEMYVWGAYSAINYNHIL
LKDYKLVKKPLYTPLKYLPPRKKRGLGLTLALVTATTAGLIGTTTGTSALAVSLKLKEVM
LQQSQINEATLGMLKILQRRLKQAERVILTLHQRVSRIERYLEIQYQLRGMCPFKDICEI
PGNGNFTNYNDSWAIGRWAEQAEEDWQQFGTIVKQCNRTNENLKNDLEKLSIDSWLSWNP
LGNVFQMLITLIIIIGMGVILKGCILNCCKILMASMGYKRVAEEMVILPDSELDSESEIE
LNVTEKEKKPMVNSGKEESDEEF